Circulating Tumor Cell (CTC) Diagnostics

Global Market Trajectory & Analytics

MCP-7869

EXECUTIVE ENGAGEMENTS

POOL

2011
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

362
Interactions with Platform & by Email

PARTICIPANTS

62
Unique # Participated

VALIDATIONS

18
Responses Validated*

COMPANIES

48
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2022

TABLES

122

PAGES

196

EDITION

18

PRICE

USD 5450

CODE

MCP-7869


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

S M N T

%

VALIDATED RESEARCH *

S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T

* S = Strong; M = Moderate; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Circulating Tumor Cell (CTC) Diagnostics estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$19 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. CTC Enrichment Methods, one of the segments analyzed in the report, is projected to record a 17.8% CAGR and reach US$9.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the CTC Detection Methods segment is readjusted to a revised 17% CAGR for the next 7-year period.
The Circulating Tumor Cell (CTC) Diagnostics market in the U.S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 16.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.4% and 14.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.
In the global CTC Analysis segment, USA, Canada, Japan, China and Europe will drive the 16.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$3.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.3 Billion by the year 2027.

SELECT PLAYERS

ApoCell, Inc.; Biocep Ltd.; Biocept, Inc.; Biofluidica Microtechnologies LLC; Celltraffix Inc.; Clearbridge Biomedics; Creatv Microtech, Inc.; Cynvenio Biosystems, Inc.; Fluxion Biosciences, Inc.; Ikonisys, Inc.; IVDiagnostics, Inc.; Janssen Diagnostics LLC; QIAGEN Hannover GmbH; Rarecells Sas; Screencell; Stemcell Technologies, Inc.

SEGMENTS

» Technology (CTC Enrichment Methods, CTC Detection Methods, CTC Analysis) » Application (Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research, Other Applications)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Market Outlook
Recent Market Activity
Clinical Relevance of CTCs
CTC Detection - Real-Time 'Liquid Biopsy' Scores Over Surgical Biopsy
Major Challenges in CTC Diagnostics
Need for CTC Enrichment and Popular Methods
CTC Enrichment Techniques
Select Available CTC Detection Technologies
Select CTC Isolation Systems - A Brief Comparison
CTC Identification - Various Approaches
CTC Identification Approaches
List of mRNA Markers for RT-PCR–based Detection of CTCs by Tumor Type
CellSearch System™ - The First FDA Approved Automated Enrichment/Isolation Technique
Rising Incidence of Cancer - An Opportunity Indicator
Cancer Prone Sites based on Age
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
ApoCell, Inc. (US)
Biocep Ltd. (Israel)
Biocept, Inc. (US)
Biofluidica Microtechnologies LLC (US)
Celltraffix Inc. (US)
Clearbridge Biomedics (Singapore)
Creatv Microtech, Inc. (US)
Cynvenio Biosystems, Inc. (US)
Epic Biosciences Inc. (US)
Fluxion Biosciences, Inc. (US)
Ikonisys, Inc. (US)
IVDiagnostics, Inc. (US)
Janssen Diagnostics LLC (US)
QIAGEN Hannover GmbH (Germany)
RARECELLS SAS (Italy)
ScreenCell (France)
STEMCELL Technologies, Inc. (Canada)
3. MARKET TRENDS & DRIVERS
Liquid Biopsy - the New Buzzword in Healthcare
Select Companies Active in Cancer Liquid Biopsy
CTCs for Personalized Cancer Treatment
Microfluidic Chip-based Technologies - A Promising Avenue for Cancer Diagnosis
CTC Microdevices Hog the Limelight
Increasing Research Reveal Further Complexities to CTC Composition and Behavior
EpCAM Glycoprotein - Insufficient for CTC Detection
New Isolation Techniques Show Promise in Detecting EpCAM-Negative CTCs
Physical Property-based Enrichment Technologies Lose Fizz
Evidence in Favor CTC Heterogeneity Gains Strength
CTC Clusters Raise Research Interest
Detection of EMTs Gains Precedence in the Backdrop of Recent Research Findings
Limitations of CTC Technology for Point-of-Care Testing
CTC Technologies Offer an Edge over Imaging Tests for Breast Cancer Prognosis
Limited Biomarkers Utilized In CTC Diagnostics - A Threat to Market Growth?
Select Research Findings in Recent Years
Microfluidic Device with Micro-Hall Sensors Detect CTCs with Higher Sensitivity and Specificity
NBiomics Makes its Contribution to CTC Diagnosis
Researchers at University of Michigan Develop Revolutionary Capture CTCs Method
Dean Flow Fractionation to Overcome Limitations Associated with Conventional Biomarker Analysis
Gold Nanoparticles Help in the Detection of CTCs
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for CTC Enrichment Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for CTC Enrichment Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for CTC Enrichment Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for CTC Detection Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for CTC Detection Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for CTC Detection Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for CTC Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for CTC Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for CTC Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Cancer Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Cancer Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cancer Stem Cell Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for EMT Biomarkers Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for EMT Biomarkers Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for EMT Biomarkers Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Tumorgenesis Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Tumorgenesis Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Tumorgenesis Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
China Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
France Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - CTC Enrichment Methods, CTC Detection Methods and CTC Analysis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for CTC Enrichment Methods, CTC Detection Methods and CTC Analysis for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research and Other Applications for the Years 2012, 2020 & 2027
Total Companies Profiled: 48

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com